OnabotulinumtoxinA Improves Urodynamic Outcomes in Patients with Neurogenic Detrusor Overactivity

Rovner E1, Dmochowski R2, Chapple C R3, Thompson C4, Lam W4, Haag-Molkenteller C4

Abstract Category

Detrusor Overactivity

Abstract 337
Non-Discussion Posters
Scientific Non Discussion Poster Session 29
1. MUSC Health Urology Services, Charleston, SC, USA, 2. Vanderbilt University Medical Center, Nashville, TN, USA, 3. Royal Hallamshire Hospital, Sheffield, UK, 4. Allergan, Inc., Irvine, CA, USA
Links

Abstract